TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00866853 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00866853 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01412554 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03473678 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00264927 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00401713 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00401713 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03358407 — Predictive Biomarker (PRD): RIPK2 mRNA
Genes: RIPK2; CARDIAK; RICK; RIP2; UNQ277/PRO314/PRO34092
Study NCT03495570 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04927182 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04927182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04049383 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00678184 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01904123 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT04081220 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT01107808 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03151096 — Safety Biomarker (SAF): MTHFR
Study NCT02250846 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01538927 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00280943 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03034304 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02926768 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02926768 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02513901 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT00351130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05822778 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02539953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03872570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03156426 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00158899 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00158899 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03030703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03307759 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02951182 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02951182 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT01498367 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02049008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02049008 — Safety Biomarker (SAF): Interleukin 1
Study NCT02049008 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT02049008 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02331251 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03583177 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT02915393 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT00680589 — Predictive Biomarker (PRD): DCT mRNA
Genes: DCT; TYRP2
Study NCT00515983 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00515983 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study NCT00515983 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT00515983 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT00515983 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT00515983 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00031551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04502225 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01921192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03356470 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02334774 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT04249557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00143013 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT02031601 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01319188 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03818685 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03818685 — Predictive Biomarker (PRD): PDCD1LG2 mRNA
Genes: PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2
Study NCT03701815 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03701815 — Safety Biomarker (SAF): BDNF
Study NCT04330885 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study NCT03015610 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03015610 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03093831 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02738736 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05152043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04025411 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT03823560 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02838433 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02838433 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT00074711 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00074711 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00005703 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03260881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03260881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04008329 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03728322 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT01591109 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01591109 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01591109 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT00845741 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04446533 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04719208 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01607554 — Predictive Biomarker (PRD): ISG15 mRNA
Genes: ISG15; G1P2; UCRP
Study NCT02392377 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00807859 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01852786 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02659657 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03560882 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00297219 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00060528 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00060528 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01990209 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01952223 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00306800 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT05052346 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01274949 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02113930 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02113930 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02113930 — Predictive Biomarker (PRD): MAGT1 mRNA
Genes: MAGT1; IAG2; PSEC0084; UNQ628/PRO1244
Study NCT02113930 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02113930 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02113930 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study NCT00078611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04582968 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04582968 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04582968 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT04582968 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02788903 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04704492 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00055523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03824379 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01127139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02368496 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00176579 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03662477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01759368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02948569 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT00780429 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01393327 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04068623 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04068623 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT04068623 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02245906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02245906 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02245906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02245906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02925182 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT00102609 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00322673 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00322673 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00322673 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT03709420 — Safety Biomarker (SAF): HSD17B1 mRNA
Genes: HSD17B1; E17KSR; EDH17B1; EDH17B2; EDHB17; SDR28C1
Study NCT03975595 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00006319 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT02396745 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT03870919 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03870919 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03870919 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03870919 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03870919 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02564354 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01311375 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02162719 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02162719 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT02923843 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT00069238 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT01531166 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00194519 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02880631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01845051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02879422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00697502 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04278001 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01947010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02230553 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02230553 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03446157 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03446157 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03664297 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03664297 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01793428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01319994 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05820880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01795027 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02440230 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00930696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00675805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04196959 — Predictive Biomarker (PRD): TYR mRNA
Genes: TYR
Study NCT02824133 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01113359 — Predictive Biomarker (PRD): MICB mRNA
Genes: MICB; PERB11.2
Study NCT01113359 — Predictive Biomarker (PRD): AGTR2 mRNA
Genes: AGTR2
Study NCT03017963 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03458338 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03458338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04420377 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02051764 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02807558 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT03215511 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT03215511 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT03215511 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT04017039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02249338 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT02249338 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04888442 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01225029 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT00901277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02329444 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03922100 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03922100 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03922100 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT05694104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03600909 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03600909 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02325739 — Predictive Biomarker (PRD): FGFR4 mRNA
Genes: FGFR4; JTK2; TKF
Study NCT02325739 — Predictive Biomarker (PRD): KLB mRNA
Genes: KLB
Study NCT00400777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00460200 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04012138 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04162340 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02957968 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02957968 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02957968 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04202848 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04202848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04202848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04202848 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04202848 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00555919 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00582868 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03293108 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00599885 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01122251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00114413 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01917058 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT00945126 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04388241 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02931071 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02931071 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT01771328 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01771328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01407627 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00032188 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01698489 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01698489 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01698489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01698489 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01698489 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00096902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03725670 — Predictive Biomarker (PRD): ARSA mRNA
Genes: ARSA
Study NCT01380262 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01380262 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02257268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00330083 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04701229 — Predictive Biomarker (PRD): RBM22 mRNA
Genes: RBM22; ZC3H16; 199G4
Study NCT04701229 — Predictive Biomarker (PRD): SLU7 mRNA
Genes: SLU7
Study NCT04404712 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study NCT02715362 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT03799445 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02120690 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study NCT03457220 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03363373 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04554355 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00101374 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04293380 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT00452127 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00452127 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04017286 — Predictive Biomarker (PRD): ITIH3 mRNA
Genes: ITIH3
Study NCT04017286 — Predictive Biomarker (PRD): CACNB2 mRNA
Genes: CACNB2; CACNLB2; MYSB
Study NCT03451162 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03025386 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT03904355 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02472600 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT00180921 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01033110 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04472910 — Predictive Biomarker (PRD): GATA6 mRNA
Genes: GATA6
Study NCT03367676 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03316625 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02452307 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00898027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00898027 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02654886 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01866540 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03533673 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT02094755 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT03433248 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06367010 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06367010 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA